openPR Logo
Press release

Investigation announced for Investors in Cryoport, Inc. (NASDAQ: CYRX) over potential Wrongdoing

An investigation on behalf of investors in Cryoport, Inc. (NASDAQ: CYRX) shares over potential wrongdoing at Cryoport, Inc.

An investigation on behalf of investors in Cryoport, Inc. (NASDAQ: CYRX) shares over potential wrongdoing at Cryoport, Inc.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Cryoport, Inc.

Investors who purchased shares of Cryoport, Inc. (NASDAQ: CYRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Cryoport, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Brentwood, TN based Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cryoport, Inc. reported that its annual Total Revenue rose from $222.60 million in 2021 to $237.27 million in 2022, and that its Net Loss declined from $275.52 million in 2021 to $37.33 million in 2022.

On July 12, 2023, after market hours, Cryoport, Inc. announced preliminary second-quarter financial results, and disclosed that its second quarter 2023 total revenue "is expected to be in the range of $56.5 to $57.5 million, representing a decrease of 11%, at the midpoint, compared to the second quarter of 2022." The Company attributed the shortfall to "a global slowdown in capital equipment investment" as well as "a number of clinical trial start delays and several key customers falling short of their forecasts for the revenue ramp of certain cell and gene therapies."

Shares of Cryoport, Inc. (NASDAQ: CYRX) declined from $29.98 per share on October 27, 2022, to as low as $14.00 per share on August 03, 2023.

Those who purchased shares of Cryoport, Inc. (NASDAQ: CYRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Cryoport, Inc. (NASDAQ: CYRX) over potential Wrongdoing here

News-ID: 3493226 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Cryoport

Diagnostic Shipper Market Booms as Demand for Safe Transport of Clinical Samples …
Market Overview The Diagnostic Shipper Market encompasses specialized packaging solutions designed to maintain critical temperature ranges for medical specimens, pharmaceuticals, and diagnostic samples during transit. These products combine advanced insulation, phase-change materials, and innovative container designs to safeguard integrity and extend shelf life. The advantages of diagnostic shippers include precise thermal control, compliance with international shipping regulations, and compatibility with diverse transport modes from air freight to ground courier. Growing demand
Medical Specimen Tracking System Market Set to Witness Significant Growth by 202 …
The medical specimen tracking system market is estimated to be valued at USD 926.8 Mn in 2025 and is expected to reach USD 1,925.4 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.0% from 2025 to 2032. A new study titled Medical Specimen Tracking System Market 2025, published by the Coherent Market Insights, offers information on regional and global markets that is expected to increase in value between
Medical Specimen Tracking System Market Generated Opportunities, Future Scope 20 …
The medical specimen tracking system market is estimated to be valued at USD 926.8 Mn in 2025 and is expected to reach USD 1,925.4 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.0% from 2025 to 2032. Latest Report, titled "Medical Specimen Tracking System Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights
Cell & Gene Therapy Supply Chain Software Market Key Players Analysis - Azenta L …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Cell & Gene Therapy Supply Chain Software Market Size, Share & Trends Analysis Report By Business Type (Transport, Warehouse, Distribution, Value-Added Services), Mode Of Operation (Storage, Roadways, Seaways), And End Use, Region, Market Outlook And Industry Analysis 2031" The Cell & Gene Therapy Supply Chain Software Market is poised for significant growth, projected to surpass USD 668.4
Vaccine Cold Chain Logistics Market Top Players - Cryoport (U.S.), DHL Express ( …
Vaccine Cold Chain Logistics Market worth $4.59 billion by 2028 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market research report on "Vaccine Cold Chain Logistics Market- By Services (Storage, Packaging, and Transportation), By Packaging Methods (Dry Ice, Liquid Nitrogen, Gel Packs), Industry Competition Analysis, COVID-19 Impact Analysis, Revenue (US$ Billions) and Forecast Till 2028." Get Free Access to Demo Report, Excel Pivot
Cell Therapy Packaging Products and Services Market Top Companies Study - Almac, …
Cell Therapy Packaging Products and Services Market worth $1.25 Billion by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell Therapy Packaging Products and Services Market (Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies, and Other ATMPs), Package Engineering Design (Primary Packaging and Secondary Packaging), Scale of Operation (Clinical and Commercial))- By Trends, Industry Competition